Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses.
Kochin V, Kanaseki T, Tokita S, Miyamoto S, Shionoya Y, Kikuchi Y, Morooka D, Hirohashi Y, Tsukahara T, Watanabe K, Toji S, Kokai Y, Sato N, Torigoe T. Kochin V, et al. Among authors: sato n. Oncoimmunology. 2017 Feb 16;6(4):e1293214. doi: 10.1080/2162402X.2017.1293214. eCollection 2017. Oncoimmunology. 2017. PMID: 28533942 Free PMC article.
Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-A24-recoverin tetramer.
Rong S, Ikeda H, Sato Y, Hirohashi Y, Takamura Y, Sahara H, Sato T, Maeda A, Ohguro H, Sato N. Rong S, et al. Among authors: sato t, sato y, sato n. Cancer Immunol Immunother. 2002 Jul;51(5):282-90. doi: 10.1007/s00262-002-0282-6. Epub 2002 Apr 24. Cancer Immunol Immunother. 2002. PMID: 12070715 Free PMC article.
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma.
Sato Y, Nabeta Y, Tsukahara T, Hirohashi Y, Syunsui R, Maeda A, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Wada T, Yamashita T, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Umeda T, Ishii S, Kawaguchi S, Sato N. Sato Y, et al. Among authors: sato n. J Immunol. 2002 Aug 1;169(3):1611-8. doi: 10.4049/jimmunol.169.3.1611. J Immunol. 2002. PMID: 12133991
Improved generation of HLA class I/peptide tetramers.
Sato Y, Sahara H, Tsukahara T, Kondo M, Hirohashi Y, Nabeta Y, Kawaguchi S, Ikeda H, Torigoe T, Ichimiya S, Tamura Y, Wada T, Yamashita T, Goto M, Takasu H, Sato N. Sato Y, et al. Among authors: sato n. J Immunol Methods. 2002 Dec 20;271(1-2):177-84. doi: 10.1016/s0022-1759(02)00329-0. J Immunol Methods. 2002. PMID: 12445740
Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells.
Kondo H, Sahara H, Miyazaki A, Nabeta Y, Hirohashi Y, Kanaseki T, Yamaguchi A, Yamada N, Hirayama K, Suzuki M, Hamuro J, Torigoe T, Takahashi N, Kohama GI, Ikeda H, Sato N. Kondo H, et al. Among authors: sato n. Jpn J Cancer Res. 2002 Aug;93(8):917-24. doi: 10.1111/j.1349-7006.2002.tb01338.x. Jpn J Cancer Res. 2002. PMID: 12716470 Free PMC article.
5,479 results